Bataller R, Arroyo V, Ginès P, Sort P
Liver Unit, Institute Clinic of Digestive Diseases, University of Barcelona, Barcelona, Spain.
Forum (Genova). 1998 Jan-Mar;8(1):62-81.
The hepatorenal syndrome is a severe and common complication of patients with advanced cirrhosis and ascites. It is characterised not only by renal failure but also by marked alterations in systemic haemodynamics. Renal failure is due to a marked hypoperfusion of the kidney secondary to renal vasoconstriction. Although the pathogenesis of hepatorenal syndrome is not completely understood, it is thought to be the extreme manifestation of the underfilling of the arterial circulation secondary to an arterial vasodilation, located mainly in the splanchnic circulation. Recently, a revised definition and diagnostic criteria of hepatorenal syndrome have been proposed. The prognosis of patients with hepatorenal syndrome is very poor. Liver transplantation is the only effective treatment but it is not applicable in most cases due to short survival. New therapies developed during the last years, such as the use of systemic vasoconstrictors or transjugular intra-hepatic portosystemic shunts appear to be promising, but prospective investigations are needed to delineate their real usefulness.
肝肾综合征是晚期肝硬化和腹水患者严重且常见的并发症。其不仅以肾衰竭为特征,还伴有全身血流动力学的显著改变。肾衰竭是由于肾血管收缩继发肾脏明显灌注不足所致。尽管肝肾综合征的发病机制尚未完全明确,但一般认为它是主要位于内脏循环的动脉血管扩张继发动脉循环血容量不足的极端表现。最近,有人提出了肝肾综合征的修订定义和诊断标准。肝肾综合征患者的预后很差。肝移植是唯一有效的治疗方法,但由于患者生存期短,在大多数情况下并不适用。近年来开发的新疗法,如使用全身血管收缩剂或经颈静脉肝内门体分流术,似乎很有前景,但需要进行前瞻性研究来确定其实际疗效。